Joshua Mitchell

21PUBLICATIONS
86CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 09, 2026
Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

|May 27, 2026
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries.

|May 20, 2026
Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

|Dec 23, 2025
Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter Study.

Maximilian L Müller, Fabian Knebel, Katrin Hahn

|Nov 26, 2025
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis.

Joshua D Mitchell, Michael Pfeiffer, John Boehmer

|Jan 27, 2025
Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications.

Maximilian Leo Müller, Anna Brand, Isabel Mattig

Pageof 4

Frequent Collaborators

3 joint publications

Bonnie Ky

2 joint publications

Gerard M Walls

2 joint publications

Michael Pfeiffer

2 joint publications

Ulf Landmesser